Patent applications published 22 June 2011
Selected patent applications from the weekly European Patents Bulletin
- Topical formulations for treatment of neuropathy
Taraxos 2334176*
- Peptide toxin formulation
Vestaron 2334177*
- Compsns and methods for the treatment of bowel diseases with granulated mesalamine
Dr Falk Pharma 2334178*
- AHCY hydrolase inhibitors for treatment of hyper homocysteinemia
Merck Sharp & Dohme 2334179*
- Alleviating disorders with combining agents that increase epoxygenated fatty acids and agents that increase CAMP
The Regents of the University of California 2334180*
- Phthalimide derivative metabotropic glutamate ligands
Merck Sharp & Dohme 2334181*
- Method of treating organophosphorus poisoning
University of Maryland; The Government of the United States as Represented by the Secretary of the Army 2334182*
- Sulphonamide derivative metabotropic glutamate R4 ligands
Merck Sharp & Dohme 2334183*
- Fungicidal mixture, containing fenpropidin and penxonazole
Syngenta Participations 2334184*
- Compsns and methods of using (R)-pramipexole
Knopp Neurosciences 2334185*
- Compacted cinacalcet
Ratiopharm 2334284*
- Improvements in the absorption of thera-peutic agents across mucosal membranes or the skin
Critical Pharmaceuticals 2334285*
- Low pH retinoid topical compsns
Amcol International 2334286*
- Hot-melt extrusion of modified release multi-particulates
Board of Regents, The University of Texas System 2334297*
- Microencapsulation process with solvent and salt
Surmodics Pharmaceuticals 2334288*
- Controlled release nimesulide compsn
Europharmaceuticals 2334289*
- Drug delivery system for econazole, moxifloxacin, and rifampicin
Lifecare Innovations 2334290*
- Compsns for percutaneous administration
Novartis 2334291*
- Method of determining a phosphorus binder dosage for a dialysis patient
Fresenius Medical Care Holdings 2334292*
- Compsns comprising polyhydroxylate fatty alcohol derivatives and the therapeutic uses
Meretzki, Shai 2334293*
- Compsn for the treatment of alopecia
ProxiPHARM 2334294*
- Pharmaceutical compsn comprising eixosapentenoic acid and nicotinic acid and methods of using same
Amarin Corp; Manku, Mehar 2334295*
- Immunomodulating activities
Novogen Research 2334296*
- Lofexidine enantiomers for use as a treatment for CNS disease and pathologies and its chiral synthesis
Agean 2334297*
- Novel single unit carbapenem amidoglycoside formulations
Chaudhary, Manu 2334298*
- Pharmaceutical compsn comprising gaboxadol and an inhibitor of PATL or OAT
H Lundbeck 2334299*
- Compsn and method for treatment of preterm labour
The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin 2334300*
- Macrocyclics pyrimidines as aurora kinase inhibitors
Merck Serono 2334301*
- Dosage forms for weakly ionisable compounds
Cima Labs 2334302*
- Tyrosine kinase receptor TYR03 as a therapeutic target in the treatment of cancer
Institut Curie; Centre National de la Recherche Scientifique; Universite Paris-Est Cretil val de Marne 2334303*
- Therapeutic bone growth and regeneration
Agency for Science, Technology & Research, Singapore 2334304*
- Bioadhesive constructs
KNC NER Acquisition Sub 2334305*
- Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
The General Hospital Corp 2334306*
- Multilayered blood products
Reapplix 2334307*
- Treating or preventing gout
Fonterra Corporate Research and Development; Fonterra 2334308*
- TH1 vaccination priming for active immunotherapy
Immunovative Therapies 2334309*
- Adherent cells from placenta tissue and use thereof in therapy
Pluristem 2334310*
- Non-typeable haemophilus influenzae vaccines and their uses
Hunter Immunology 2334311*
- Compsns comprising plant extracts and use thereof for treating inflammation
Nutriquine; Chamberland, Guy 2334312*
- Process for the preparation of pramlintide
ScinoPharm Taiwan 2334314*
- Agents and methods for treatment of pain
Abor Vita Corp; Nono 2334315*
- Process for the synthesis of (AIB8,35)HGLP-1(7,36)-NH2
Ipsen Manufacturing Ireland 2334316*
- Stapled peptides and method of synthesis
The Research Foundation of the State University of New York 2334317*
- HIV-1 integrase derived stimulatory peptides interfering with integrase-rev protein binding
Yissum Research Development Company of the Hebrew University of Jerusalem 2334318*
- Method of reducing scarring during wound healing using antisense compounds directed to CTGF
Excaliard Pharmaceuticals; Northwestern University 2334319*
- Biopolymer conjugates comprising an interleukin-11 analogue
Viromed; Biopolymed 2334320*
- Analysis of HCV genotypes
Vertex Pharmaceuticals 2334321*
- GLP-1 fusion polypeptides
Asterion 2334322*
- Compsns and methods for the prevention of oxidative degradation of proteins
F Hoffmann-La Roche 2334323*
- BBeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury
Fibrex Medical Research & Development 2334324*
- Process for treatment of rheumatoid arthritis, tremors/Parkinson’s disease, multiple sclerosis and non-viral based cancers
Salubrious Pharmaceuticals 2334325*
- Mimotypes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
Affris 2334326*